Volume : 09, Issue : 12, December – 2022
Title:
99.FORMULATION, DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLETS OF TERFENADINE
Authors :
Ragini Gour*, Ms. Chanchal Jain, Dr. Navjot Singh
Abstract :
Terfenadine is an antihistamine formerly used for the treatment of allergic conditions. Terfenadine, an H1-receptor antagonist antihistamine, is similar in structure to astemizole and haloperidol, a butyrophenone antipsychotic. The active metabolite of terfenadine is fexofenadine. The aim of present work was to develop fast dissolving tablets of Terfenadine by direct compression method using different binders Sodium starch glycolate, croscarmellose sodium and microcrystalline cellulose. The prepared tablets were evaluated for parameters such as hardness, friability, drug content, weight variation, in-vitro disintegration time, in vitro dissolution studies and stability studies. Disintegration Time of different prepared formulation F1, F2, F3, F4, F5 and F6 was found to be 105±4, 98±3, 95±5, 68±4, 43±2, and 55±1sec., the minimum Disintegration time was found in formulation F5 (43±2 sec.), select as optimized formulation.When the regression coefficient values of were compared, it was observed that ‘r2’ values of Higuchi release kinetics was maximum i.e.0.992 hence indicating drug release from formulations was found to follow Higuchi release kinetics.
Keywords: Fast dissolving tablets, Superdisintegrants, Terfenadine, Crosspovidone, Sodium carboxy methyl cellulose. Direct Compression.
Cite This Article:
Please cite this article in press RaginiGouret al,Formulation, Development And Evaluation Of Fast Dissolving Tablets Of Terfenadine..,Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
1. Hannan PA, Khan JA, Khan A, Safiullah S. Oral dispersible system: a new approach in drug delivery syste. Indian J Pharm Sci. 2016; 78:2-7.
2. Bhowmik D, Chiranjib B, Krishnakanth, Pankaj, Chandira RM. Fast dissolving tablet: an overview. J Chem Pharm Res. 2009; 1:163-77.
3. Siddiqui N, Garg G, Sharma PK. Fast dissolving tablets: preparation, characterization and evaluation: an overview. Int J Pharm Sci Rev Res. 2010; 2:87-96.
4. Gupta DK, Bajpai M, Chatterjee DP. Fast mouth is dissolving disintegrating tablet and patient counselling points for FDDTS: A review. Int J Res Dev Pharm L Sci. 2014; 3:949-58.
5. Nautiyal U, Singh S, Singh R, Gopal, Kakar S. Fast dissolving tablets as a novel boon: A review. J Pharm Chem Biol Sci. 2014; 2:5-26.
6. Okuda, Y.; Irisawa, Y.; Okimoto, K.; Yamashita, S.Further improvement of orally disintegrating tablets usingmicronized ethylcellulose. Int. J. Pharm.,, p.01-09, 2011.
7. Parmar, R.; Baria, A.; Tank, H.; Faldu, S. Formulationand evaluation of domperidone fast dissolving tablets. Int.J. Pharm. Tech. Res., v.1, n.3, p.483-487, 2009.
8. Prameela, A.; Archana, P.; Siva teja, P.; Vikas M.Formulation and evaluation of orodispersible metformintablets: A Comparative study on hisapghula husk andcrospovidone as superdisintegrants. Int. J. Appl. Pharm.,v.2, n.3, p.15-21, 2010.
9. Puttewar, T.; Kshirsagar, M.; Chandewar,A.; Chikhale, R. Formulation and evaluation oforodispersible tablet of test masked doxylamine succinateusing ion exchange resin. J. King Saud Univ. Sci., v.22,p.229-240, 2010.
10. Sayeed, A.; Mohiuddin, M. Mouth dissolving tablets anoverview. Int. Res. Pharm. Biomed. Sci., v.2, n.3, p.959-970, 2011.
11. Shah, V.; Patel, S.; Rakesh, K. Formulation andevaluation of mouth dissolving tablets of metoclopramidehydrochloride by direct compression technique.Int. J. DrugDisc. Herbal Res., v.1, n.2, p.100-103, 2011.
12. Shirsand, S.; Para, M.; Ramani, R. Novel co-processedsuperdisintegrants in the design of fast dissolving tablets.Int.J. Pharm. Tech. Res., v.2, n.1, p.223-227, 2010.
13. Sugimoto, M.; Narisawa, S.; Matsubara, K.Development of manufacturing method for rapidly rapidlydisintegrating oral tablets using the crystalline transition ofamorphous sucrose. Int. J. Pharm., v.320, p.71-78, 2006.
14. Suresh, S.; Senthil, A.; Manikandan, C. Formulationand evaluation of mouth dissolving tablets of amlodipinebesylate. Int. Res.J. Pharm., v.2, n.9, p.161-165, 2011.